Some employers are adding psychedelic drugs to their roster of health  benefits

Some employers are adding psychedelic drugs to their roster of health benefits

5
(702)
Write Review
More
$ 31.00
Add to Cart
In stock
Description

An increasing number of employers are giving their workers access to psychedelic-assisted psychotherapy as part of their health plan. 

Psychedelics are having a moment and women could be the ones to benefit

Ketamine Retreats Seek to Help Professionals Find Work-Life Balance - Bloomberg

Psychedelic Drugs Market: A Promising Frontier in Mental Health Treatment

The obstacles to decriminalizing psychedelic drugs are political, not legal, say experts - Harvard Law School

Psychedelic-Assisted Therapy: Applications in Mental Health

Psychedelic Drugs Market Forecast to Reach $6.4 Billion by 2034: Psilocybin and Ketamine Therapies Gain Traction, Driving the Market at 12.17% CAGR

Frontiers Associations between the use of psychedelics and other recreational drugs with mental health and resilience during the COVID-19 pandemic

The Psychedelic Rx

Psychedelic drugs development landscape witnessing remarkable surge: GlobalData, ET HealthWorld

Psychedelic Medicine: Past, Present, and Future